Division of Hematologic Malignancies & Hematopoietic Stem Cell Transplantation
Leadership
- Director, Division of Hematologic Malignancies & Cellular Therapy
- Program Leader, Immune Cell Regulation & Targeting (IRT)
- Co-Director, Blood Cancer Center of Excellence (BCCE)
- Professor of Medical Oncology; Dermatology, & Cutaneous Biology
834 Chestnut Street
Suite 320
Philadelphia, PA 19107
For Patient Inquiries
New Patients: 1-800-JEFF-NOW
Existing Patients: 215-955-8874
Blood & Marrow Transplant Program
The Blood & Marrow Transplant (BMT) team at Jefferson delivers the skilled and comprehensive care you need. Jefferson is advancing the state of the art in this field, and is capable of successfully performing transplants that are not undertaken by most transplant centers around the country.
Hematologic Cancers Program
Designated a center of excellence in cancer care and research, Thomas Jefferson University Hospitals' Kimmel Cancer Center treats patients with hematological malignancies, the most common forms of which are leukemia (acute and chronic myelogenous and lymphocytic), Hodgkins and non-Hodgkins lymphoma and multiple myeloma.